1-2 of 2
Matthew Miller, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Clinical Study of Tomaralimab (OPN-305), a Toll-like Receptor 2 (TLR-2) Antibody, in Heavily Pre-Treated Transfusion Dependent Patients with Lower Risk Myelodysplastic Syndromes (MDS) That Have Received and Failed on Prior Hypomethylating Agent (HMA) Therapy

Guillermo Garcia-Manero, MD, Elias J. Jabbour, MD, Marina Y. Konopleva, MD PhD, Naval G. Daver, MD, Gautam Borthakur, MD, Courtney D. DiNardo, MDMSc, Prithviraj Bose, MD, Parita Patel, Rami S. Komrokji, MD, Aditi Shastri, MD, Gail J. Roboz, MD, Robert Matthew Miller, MD, Sarah Arbe-Barnes, PhD, Mary Reilly, MSc, Peter McGuirk, PhD, Tara Kearney, Brian Keogh, PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 798.
https://doi.org/10.1182/blood-2018-99-119805
Published: 2018
Journal Articles

Improved Recognition of Hematogones from B Lymphoblastic Leukemia By 5-Color Flow Cytometric Analysis

Amanda Lo, MD, Matthew Miller, MD, Melissa Cervania, Melissa Cervania, MT (ASCP) SI, QCYM, CCy, Quanlin Li, MS, Mark David Ewalt, MD, Qin Huang, MD, PhD, Serhan Alkan, MD
Journal: Blood
Blood (2016) 128 (22): 1732.
https://doi.org/10.1182/blood.V128.22.1732.1732
Published: 2016